Shiv Generic Medicine Private Limited
About Shiv Generic Medicine Private Limited
Data last updated:
Shiv Generic Medicine Private Limited is a private limited company based in Hadapsar, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24290PN2019PTC184517.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹60,000. It is led by directors Manjusha Santosh Shedge and Santosh Mansing Shedge.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at S.No.19/2/1 Gondhale Nagar Shop No.2 Kale Complex, Hadapsar, Maharashtra, India – 411028.
As per the financials filed for FY 2022, the company reported a revenue of ₹38.61 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹59,730 (net margin 1.5%) and EBITDA of -₹3.69 Lakh (EBITDA margin -9.6%).
Company details
Contact details
Shiv Generic Medicine Private Limited's registered office is in Hadapsar, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS.No.19/2/1 Gondhale Nagar Shop No.2 Kale Complex, Hadapsar, Maharashtra, India – 411028
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shiv Generic Medicine Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shiv Generic Medicine is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Shiv Generic Medicine Private Limited
FY 2022 filings availableShiv Generic Medicine Private Limited reported revenue of ₹38.61 Lakh (up 4103% YoY) for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹3.69 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹59,730 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -9.6% | ||
| Net Profit Margin | 1.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Shiv Generic Medicine Private Limited, buy the company report.
Board of directors of Shiv Generic Medicine Private Limited
Shiv Generic Medicine has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manjusha Santosh Shedge | Director | 30 Sep 2024 | 2 Years 1 Months | Current |
| Santosh Mansing Shedge Also directs: Shade Labs LLP, Genivis Remedies India Private Limited | Director | 31 May 2019 | 7 Years 5 Months | Current |
Auditor
Shiv Generic Medicine Private Limited is audited by JAGTAP AND JAGTAP LLP for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAGTAP AND JAGTAP LLP | FY 2021 | W100137 |
Shareholding
The shareholding of Shiv Generic Medicine Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Shiv Generic Medicine Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shiv Generic Medicine Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shiv Generic Medicine Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Shiv Generic Medicine Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Shiv Generic Medicine Private Limited has 6 board changes on record since 2019: 3 appointments and 3 cessations. The latest: Manjusha Santosh Shedge was appointed as Director on 30 Sep 2024.
Frequently asked questions
Shiv Generic Medicine is an active private limited company based in Hadapsar, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 May 2019 (7+ years old) and is registered under CIN U24290PN2019PTC184517.
Shiv Generic Medicine has 2 current directors:
- Manjusha Santosh Shedge - Director
- Santosh Mansing Shedge - Director
The latest financial statements of Shiv Generic Medicine on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Shiv Generic Medicine is U24290PN2019PTC184517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shiv Generic Medicine was incorporated on 31 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Manjusha Santosh Shedge was appointed as Director on 30 Sep 2024. Pankaj Jagtap ceased to be Additional Director on 31 Dec 2020. Amit Hanumant Bhosale ceased to be Director on 05 Nov 2020. Shiv Generic Medicine has 6 board changes on record in total.
The registered office of Shiv Generic Medicine is at S.No.1921 Gondhale Nagar Shop No.2 Kale Complex, Hadapsar, Maharashtra, India – 411028.
Shiv Generic Medicine operates in the pharma industry, in the drug formulation and development segment.
Shiv Generic Medicine can be reached at its registered office: S.No.1921 Gondhale Nagar Shop No.2 Kale Complex, Hadapsar, Maharashtra, India – 411028.
Shiv Generic Medicine is registered under the jurisdiction of the Registrar of Companies (ROC), Pune.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
